Spence, O’Mareen https://orcid.org/0000-0003-1573-7809
Onwuchekwa Uba, Richie
Shin, Seongbin
Doshi, Peter
Article History
Received: 8 January 2018
Accepted: 13 April 2018
First Online: 3 May 2018
Ethics approval and consent to participate
: Not applicable.
: Dr. Doshi leads the RIAT Support Center, funded by the Laura and John Arnold Foundation. Dr. Doshi was a co-recipient of a UK National Institute for Health Research grant (HTA – 10/80/01 Update and amalgamation of two Cochrane Reviews: neuraminidase inhibitors for preventing and treating influenza in healthy adults and children — ) and a Cochrane Methods Innovations Fund grant to develop guidance on the use of regulatory data in Cochrane reviews. Dr. Doshi also received €1500 from the European Respiratory Society in support of his travel to the society’s September 2012 annual congress in Vienna, where he gave an invited talk on oseltamivir. Dr. Doshi gratefully acknowledges the American Association of Colleges of Pharmacy for its funding support ($11,000) for a study to analyze written medical information regarding the possible harms of statins. AACP had no involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript. Dr. Doshi is also an associate editor of The BMJ and an unpaid member of the IMEDS steering committee at the Reagan-Udall Foundation for the FDA, which focuses on drug safety research. O’Mareen Spence is recipient of a Maryland CERSI Scholar award from the Food and Drug Administration (grant #1U01FD005946). FDA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Laura and John Arnold Foundation funds the RIAT Support Center which supports the salaries of Dr. Doshi and Ms. Spence.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.